We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Croda International Plc | LSE:CRDA | London | Ordinary Share | GB00BJFFLV09 | ORD 10.609756P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -42.00 | -1.20% | 3,449.00 | 28,099 | 11:48:51 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 3,448.00 | 3,451.00 | 3,494.00 | 3,448.00 | 3,479.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chemicals & Chem Preps, Nec | 1.69B | 171M | 1.2246 | 28.25 | 4.87B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 11:48:51 | AT | 45 | 3,449.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 11/12/2024 | 15:09 | UK RNS | Croda International PLC Director/PDMR Shareholding |
| 11/12/2024 | 13:54 | UK RNS | Croda International PLC Director/PDMR Shareholding |
| 09/12/2024 | 14:36 | UK RNS | Croda International PLC Holding(s) in Company |
| 29/11/2024 | 12:12 | UK RNS | Croda International PLC Holding(s) in Company |
| 20/11/2024 | 13:42 | UK RNS | Croda International PLC Director/PDMR Shareholding |
| 19/11/2024 | 07:00 | UK RNS | Croda International PLC Directorate Change |
| 12/11/2024 | 14:47 | UK RNS | Croda International PLC Director/PDMR Shareholding |
| 11/11/2024 | 10:57 | ALNC |  EXTRA: Croda forecasts remain vulnerable despite third quarter relief |
| 11/11/2024 | 09:46 | ALNC | TOP NEWS: Croda reports sales growth across all divisions, backs guide |
| 11/11/2024 | 07:00 | UK RNS | Croda International PLC Third quarter 2024 sales update |
Croda (CRDA) Share Charts1 Year Croda Chart |
|
1 Month Croda Chart |
Intraday Croda Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 11/12/2024 | 17:33 | CRODA | 357 |
| 24/7/2018 | 21:20 | Croda Intl (CRDA) One to Watch on Wednesday | - |
| 23/7/2014 | 14:31 | TipTv analyses the prospects of Croda International PLC (CRDA) | - |
| 25/7/2012 | 19:28 | CRODA BACK TO Ј7 | 253 |
| 05/2/2007 | 14:35 | Strong Outlook | 98 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 11:48:51 | 3,449.00 | 45 | 1,552.05 | AT |
| 11:48:25 | 3,449.87 | 50 | 1,724.93 | O |
| 11:47:50 | 3,451.00 | 1 | 34.51 | O |
| 11:47:46 | 3,451.23 | 460 | 15,875.67 | O |
| 11:47:20 | 3,451.00 | 6 | 207.06 | AT |
| Top Posts |
|---|
Posted at 13/12/2024 08:20 by Croda Daily Update Croda International Plc is listed in the Chemicals & Chem Preps, Nec sector of the London Stock Exchange with ticker CRDA. The last closing price for Croda was 3,491p.Croda currently has 139,635,442 shares in issue. The market capitalisation of Croda is £4,829,989,939. Croda has a price to earnings ratio (PE ratio) of 28.25. This morning CRDA shares opened at 3,479p |
Posted at 10/12/2024 09:37 by waldron Croda International’This transaction, completed on November 20, 2024, underlines Bull’s confidence in the company’s future prospects, making it an intriguing development for investors in the stock market. For further insights into GB:CRDA stock, check out TipRanks’ |
Posted at 10/12/2024 09:36 by waldron Moderate Buy6Ratings 2 Buy 4 Hold 0 Sell Based on 6 analysts giving stock ratings to Croda International in the past 3 months CRDA Stock 12 Month Forecast 4,329.17p ▲(24.80% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Croda International in the last 3 months. The average price target is 4,329.17p with a high forecast of 5,100.00p and a low forecast of 3,875.00p. The average price target represents a 24.80% change from the last price of 3,469.00p. |
Posted at 08/12/2024 09:07 by laurence llewelyn binliner CRDA seems to be tracking the GSK 12 month chart trend like for like, largely down to the vaccine / lipid arm of the businesses, quite possibly linked to the US health story and minister driving policy going forward..CRDA is better diversified, looks good value at 3400 pence and 3.2%, ignoring the CV19 spike the share price is back where it was in 2016, it was also around 5000 pence before the pandemic sell off.. 2024 - Q1/2/3 group level sales have been negative -0.25% per quarter, with growth in life sciences of +2% QonQ.. Is this the turning point for entry, the 5 year trend ex CV19 has been negative, 5000 down to 3400 today..? |
Posted at 12/7/2024 20:42 by wad collector Yes that concept can only be used for a finite period. But ultimately they are in a reasonable niche with multiple products, they will prosper again eventually if they maintain market share.They are still double what they were a decade ago. Unimpressive but steady, if we ignore the covid bonus. free stock charts from uk.advfn.com |
Posted at 03/7/2024 16:43 by uhound Depends on how the market values the company.Based on earnings and assets £30 per share? EPS has declined a lot over the last few years, but perhaps we may se a recovery this year? |
Posted at 01/7/2024 08:22 by scobak I look at the price and the fundamentals.Currently £39.20 and falling. Historically £39.52 is a good price but perhaps not a really good entry point. |
Posted at 29/6/2024 09:56 by stoopid Bought in at 3952. With the RSI below 30 and the lowest share price in around 5 years I hope it's a good entry point.... |
Posted at 28/6/2024 10:00 by stoopid But only for an hour or so and has already bounces back above.Been watching CRDA foe a while now and wondering if now is the right time to buy in? |
Posted at 27/2/2024 07:49 by battyliveson Poor numbers, but probably expected given share price movements in last couple of years.I think a fair value for croda is around £4.4 to £5.6bn, so will wait before I get back in. B |
Posted at 05/2/2024 16:38 by wad collector Bouncing off £50 atm , maybe the worse is behind CRDA now, this is an industry with high barriers to entry , but still a long way back to the heady £100 days of 2021. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
